Evidence map›Paper›PMID 33340400›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2021

A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial.

Alana M Rojewski, Lisa M Fucito, Nathaniel L Baker, Suchitra Krishnan-Sarin, Matthew J Carpenter, Steven L Bernstein, Benjamin A Toll

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. A Secondary Analysis of a Preliminary Contingency Management Intervention for Presurgical Cancer Patients: Evaluating Individual Participant Data.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Trial
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Alana M RojewskiDepartment of Public Health Sciences and Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
Lisa M FucitoDepartment of Psychiatry and Emergency Medicine, Yale School of Medicine, New Haven, CT.
Nathaniel L BakerDepartment of Public Health Sciences and Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
Suchitra Krishnan-SarinDepartment of Psychiatry and Emergency Medicine, Yale School of Medicine, New Haven, CT.
Matthew J CarpenterDepartment of Public Health Sciences and Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
Steven L BernsteinDepartment of Psychiatry and Emergency Medicine, Yale School of Medicine, New Haven, CT.
Benjamin A TollDepartment of Public Health Sciences and Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
Medical University of South Carolina · USYale Cancer Center · USYale University · USMUSC Hollings Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Contingency Management to Promote Smoking Abstinence in Cancer PatientsR01CA251158 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TOLL, BENJAMIN ANDREW · 2020 to 2024
$2.5M
Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: The Georgia-California GeneLINK InitiativeR01CA225697 · NCI · STANFORD UNIVERSITY · PI KATZ, STEVEN J., KURIAN, ALLISON W. · 2018 to 2021
$1.6M
Tobacco Treatment in the Context of Lung Cancer Screening - Administrative SupplementK07CA214839 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROJEWSKI, ALANA · 2017 to 2021
$911k
Novel Treatment to Enhance Smoking Cessation before Cancer SurgeryR21CA181569 · NCI · YALE UNIVERSITY · PI TOLL, BENJAMIN ANDREW · 2014 to 2015
$438k
NCATS NIH HHS UL1 TR001863NCI NIH HHS K07 CA214839NCI NIH HHS R01 CA225697NCI NIH HHS R01 CA251158NCI NIH HHS R21 CA181569
6 · The paper itself

Abstract

introductionThe purpose of this study was to evaluate a pilot preoperative contingency management (CM) intervention for smoking abstinence. AIMS AND

methodsThis multisite pilot study was conducted at two cancer center-based tobacco treatment programs. Participants who were smoking, diagnosed with or suspected to have any type of operable cancer, and had a surgical procedure scheduled in the next 10 days to 5 weeks (N = 40) were randomized to receive standard care plus monitoring only (MO) or CM prior to surgery. All patients received breath carbon monoxide (CO) tests 3 times per week, nicotine patches, and counseling. The CM group also earned payments for self-reported smoking abstinence confirmed by CO breath test ≤6 ppm on an escalating schedule of reinforcement (with a reset if they smoked). Seven-day point prevalence abstinence rates on the day of surgery and at 3-month follow-up were compared between groups using repeated measures log-linear regression models utilizing generalized estimating equations. Participants lost to follow-up are assumed to have returned to smoking.

resultsThe sample was 50% female and 75% White. In covariate adjusted models, patients in the CM group had a greater probability of reported abstinence. On the day of surgery (end of treatment), 52% of CM patients were abstinent compared with 16% of patients in MO (risk ratio = 3.2 [1.1-9.3]; p = .03). At the 3-month follow-up, 43% of CM patients were abstinent compared with 5% in MO (risk ratio = 8.4 [1.5-48.3]; p = .02).

conclusionsProviding monetary incentives contingent on abstinence prior to cancer surgery may produce significant improvements in smoking abstinence rates relative to breath CO MO. IMPLICATIONS: In this pilot preoperative CM intervention for smoking abstinence, patients receiving a CM intervention prior to cancer surgery had a greater probability of smoking abstinence at the end of treatment compared with a breath MO group (52% vs. 16%, respectively). Thus, providing monetary incentives contingent on abstinence may produce significant improvements in smoking abstinence rates prior to cancer surgery relative to breath CO monitoring.

Indexed as

NeoplasmsSmoking CessationBehavior TherapyFemaleHumansMaleMiddle AgedMotivationPreoperative PeriodSmokingTobacco Use Cessation Devices

Identifiers

PMID33340400
PMCPMC8248947
OpenAlexW3116338537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.